Bone and lung metastases from intracranial meningioma

Alessandra Fabi1, Carmen Nuzzo, Antonello Vidiri

  • 1Division of Medical Oncology A, Regina Elena National Cancer Institute, via Elio Chianesi 53, 00144 Rome, Italy. alessandra.fabi@virgilio.it

Anticancer Research
|November 11, 2006
PubMed

Insights

Meningiomas, typically benign intracranial tumors, can rarely metastasize. This case highlights simultaneous bone and lung metastases from a relapsed meningioma, suggesting whole-body CT scans for monitoring.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Radiology

Background:

  • Meningiomas account for 15% of intracranial tumors, usually benign.
  • Malignant histology is rare (2-10%), with a 43% metastasis rate, most commonly to the lungs.
  • Predicting meningioma recurrence or metastasis lacks definitive criteria; WHO histological grading is key.

Observation:

  • A rare case of a woman with relapsed intracranial meningioma.
  • The patient developed simultaneous bone and intrapulmonary metastases.
  • Metastases occurred in unusual sites beyond the typical lung involvement.

Findings:

  • Histological grading is the primary predictor of meningioma malignancy.
  • This case demonstrates simultaneous bone and lung metastases from a relapsed meningioma.
  • The rarity of these specific metastatic sites underscores the unpredictable nature of the disease.

Implications:

  • Consider total body CT scans for patients with relapsed meningioma.
  • Investigate for diverse metastatic sites in recurrent meningioma cases.
  • Enhanced surveillance may improve detection of disseminated meningioma disease.